Abstract
Female SD rats with established 7, 12-dimethylbenz [a]anthracene(DMBA)-induced mammary tumours were treated with coumarin (20 mg/kg body weight; six times per week) or its metabolite 7-hydroxycoumarin (20 mg/kg) for 4 weeks. The anti-oestrogen tamoxifen (8.8 mg/kg) served as the reference drug. The inhibitory effect of coumarin was similar to that of tamoxifen [mean change of tumour area: 428% (coumarin) compared to 528% (tamoxifen); control 822%]. The strongest inhibition was observed with 7-hydroxycoumarin (248%); the difference compared to the control was significant (P<0.01). Neither coumarin nor 7-hydroxycoumarin reduced the number of tumours appearing during treatment as tamoxifen did. However, the size of the tumours treated with coumarin or its metabolite was generally much smaller than those in the tamoxifen group or in the control group. From the data obtained it appears that coumarin and 7-hydroxycoumarin inhibit the growth of tumours that have reached a certain size but do not prevent the formation of tumours after exposure to the carcinogen.
Key words: Coumarin, 7-Hydroxycoumarin, Mammary carcinoma, DMBA, Antitumour activity
Footnotes
Dedicated to Professor Dr. H.J. Roth on the occasion of his 65th birthday
References
- Angerer E von, Prekajac J, Strohmeier J (1984) 2-Phenylindoles. Relationship between structure, estrogen receptor affinity, and mammary tumor inhibiting activity in the rat. J Med Chem 27:1439–1447 [DOI] [PubMed] [Google Scholar]
- Feuer G, Kellen JA (1974) Link between carcinogenicity and hepatic metabolism of 7,12-dimethylbenz[a]anthracene. Oncology 30:499–508 [DOI] [PubMed] [Google Scholar]
- Fiebig HH, Schmähl D (1980) Endocrine and cytostatic treatment of experimental mammary cancer. In: Henningsen B, Linder F, Steichele C (eds) Endocrine treatment of breast cancer. Springer, Berlin Heidelberg New York pp 80–95 [DOI] [PubMed] [Google Scholar]
- Kokron O, Maca S, Gasser G, Schmidt RR (1991) Cimetidine und coumarin therapy of renal cell carcinoma. A pilot study. Oncology 48:102–106 [DOI] [PubMed] [Google Scholar]
- Marshall ME, Riley LK, Rhoades J, Eicchorn T, Jennings CD, Cibull M, Thompson J (1989) Effects of coumarin (1,2-benzopyrone) and cimetidine on peripheral blood lymphocytes, natural killer cells, and monocytes in patients with advanced malignancies. J Biol Response Mod 8:62–69 [PubMed] [Google Scholar]
- Maucher A (1992) Pharmakologische Untersuchungen über neue Möglichkeiten zur endokrinen und cytostatischen Behandlung des Prostatakarzinoms, PhD Thesis Regensburg
- Maucher A, Kager M, von Angerer E (1993) Evaluation of the antitumour activity of coumarin in prostate cancer models. J Cancer Res Clin Oncol 119:150–154 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moran E, Prosser E, O'Kennedy R, Thornes RD (1993) The effect of coumarin and 7-hydroxycoumarin on the growth of human tumour cell lines. J Ir Coll Physicians Surg 22[Suppl 1]:41–43 [Google Scholar]
- Rosskopf F, Kraus J, Franz G (1992) Immunological and antitumor effects of coumarin and some derivatives. Pharmazie 47:139–142 [PubMed] [Google Scholar]
- Stuhlmeier K, Theyer G, Baumgartner G, Zlabinger GJ (1991) Synergistic effect of coumarin (1,2 benzopyrone) and endotoxin in the induction of human interleukin-1. Clin Exp Immunol 84:317–323 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thornes D, Daly L, Lynch G, Browne H, Tanner A, Keane F, O'Loughlin S, Corrigan T, Daly P, Edwards G, Breslin B, Shine M, Lennon F, Hanley J, McMurray N, Gaffney E (1989) Prevention of early recurrence of high risk malignant melanoma by coumarin. Eur J Surg Oncol 15:431–435 [PubMed] [Google Scholar]
- Wakeling AE (1991) Steroidal pure antiestrogens. In: Lippman M, Dickson R (eds) Regulatory mechanisms in breast cancer. Kluwer Academic Publishers, Boston, pp 239–257 [PubMed] [Google Scholar]
- Wattenberg LW, Lam LKT, Fladmoe AV (1979) Inhibition of chemical carcinogen-induced neoplasia by coumarins and α-angelicalactone. Cancer Res 39:1651–1654 [PubMed] [Google Scholar]
- Zänker KS, Blumei G, Lange J (1984) Coumarin in melanoma patients: an experimental and clinical study. Drug Exp Clin Res 20:767–774 [Google Scholar]